United States · Investor

Sante Ventures

Last cheque observed Sep 2026; 28 cheques on record.

Deploying nowVC firm

SeedSeries ASeries BBiotechMedtechHealthtech

Deploying now
100%of best year3cheques in 12 months, 28 on record
Since the last cheque46days00hrs00min00sec
Median round$42MRounds led2 of 28Sole investor5 roundsExits1 from the portfolioMostly inUnited States, 100%
Pitch Sante Ventures

Sante Ventures highlights

  1. 01

    3 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 57% of its rounds

  3. 03

    Sole investor in 5 rounds, median $5.0M

  4. 04

    1 exits from the portfolio

What they do

Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
BiotechMedtechHealthtech
Based in
Austin, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first28 appearances

  1. 2026

    3 rounds

  2. Sept
    ReEmerge, Inc.Series A · US · Firms' own news pages$37MLed
  3. Jul
    RapidPulseSeries B · US · Longview Ventures$48MWith 7 others
  4. Apr
  5. 2025

    2 rounds

  6. Aug
    Apreo HealthSeries B · US · TechStartups$130MWith 6 others
  7. Feb
    Endovascular EngineeringSeries B · US · Firms' own news pages$42MWith 5 others
  8. 2024

    2 rounds

  9. Sept
    Ryme MedicalSeries A · US · Seroba Life SciencesUndisclosedWith 2 others
  10. Jun
    EndogenexSeries C · US · Hatteras Venture Partners$88MWith 6 others
  11. 2021

    1 round

  12. Jun
  13. 2019

    1 round

  14. Jun
    RemedySeries A · US · FinSMEs$10MSole investor
  15. 2017

    1 round

  16. Oct
    Claret MedicalSeries C · US · Massdevice$21MWith 3 others
  17. 2015

    3 rounds

  18. Nov
    BAROnovaSeries D · US$37MWith 4 others
  19. Oct
    TVA MedicalSeries C · US$15MWith 4 others
  20. Feb
    Laguna PharmaceuticalsSeries B · US$30MWith 3 others
  21. 2014

    3 rounds

  22. Aug
    Claret MedicalSeries B · US$18MWith 2 others
  23. Jul
    Molecular TemplatesVenture · US$7.0MWith 1 other
  24. Feb
    Lumos PharmaSeries A · US$14MWith 1 other
  25. 2013

    4 rounds

  26. Oct
    Molecular TemplatesSeries C · US · bioportfolio.com$8.5MWith 1 other
  27. Jun
    TVA MedicalSeries B · US · vcaonline.com$9.5MWith 2 others
  28. Jun
    EndoStimSeries D · US · bizjournals.com$14MWith 2 others
  29. Feb
    BAROnovaSeries C · US · prnewswire.com$27MWith 5 others
  30. 2012

    2 rounds

  31. Nov
    Mirna TherapeuticsSeries D · US · sec.gov$17MWith 10 others
  32. Oct
    Spinal RestorationVenture · US · in.finance.yahoo.com$5.0MWith 3 others
  33. 2010

    2 rounds

  34. Aug
    ExplorysSeries B · US · businesswire.com$2.5MSole investor
  35. Jul
    EndoStimSeries A · US · stlouis.bizjournals.com$6.0MWith 1 other
  36. 2009

    2 rounds

  37. Nov
    TerapioSeries A · US · austinstartup.com$5.0MSole investor
  38. May
    Molecular TemplatesSeries A · US · onbiovc.com$2.5MSole investor
  39. 2008

    2 rounds

  40. Dec
    BioStableSeries A · US · austin.bizjournals.com$5.5MSole investor
  41. Jul
    Zeno CorporationVenture · US · myzeno.com$28MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration4 named

DDDoug Dewitt FrenchManaging DirectoriForm ADV
JCJason Charles BrandtChief Financial Officer and Chief Compliance OfficeriForm ADV
JHJoe Hal CunninghamManaging DirectoriForm ADV
KMKevin Myles LalandeManaging DirectoriForm ADV

We also hold 41 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$1.3Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Shvms, LLC
SEC number
CRD 160280

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Sante Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Sante Ventures put money into.

Quick answers about Sante Ventures

What does Sante Ventures invest in?

Sante Ventures invests most often at Series A and Series B (57% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.

How active is Sante Ventures?

28 investments on record, 3 of them in the last 12 months, and it led 2. The most recent was in Sept 2026.

What has Sante Ventures invested in recently?

Its most recent investments on record: ReEmerge, Inc. (Series A, Sept 2026), RapidPulse (Series B, Jul 2026) and Endovascular Engineering, Inc. (“E2”) (Series C, Apr 2026).

How big are Sante Ventures's cheques?

The median round it joins is $42M.

Does Sante Ventures lead rounds?

Sometimes: it led 2 of its 28 investments on record (7%).

Where does Sante Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Sante Ventures investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

Who does Sante Ventures invest alongside?

Most often 415 Capital (3 rounds together), Epidarex Capital (3 rounds together) and Hatteras Venture Partners (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it